128 related articles for article (PubMed ID: 30612961)
1. Robotic Stereotactic Boost in Early Breast Cancer, a Phase 2 Trial.
Bondiau PY; Gal J; Chapellier C; Haudebourg J; Courdi A; Levy J; Gerard A; Sumodhee S; Maurin M; Château Y; Barranger E; Ferrero JM; Thariat J
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):374-380. PubMed ID: 30612961
[TBL] [Abstract][Full Text] [Related]
2. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
3. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
4. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.
Chadha M; Woode R; Sillanpaa J; Lucido D; Boolbol SK; Kirstein L; Osborne MP; Feldman S; Harrison LB
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):40-4. PubMed ID: 23290443
[TBL] [Abstract][Full Text] [Related]
5. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.
Rahimi A; Thomas K; Spangler A; Rao R; Leitch M; Wooldridge R; Rivers A; Seiler S; Albuquerque K; Stevenson S; Goudreau S; Garwood D; Haley B; Euhus D; Heinzerling J; Ding C; Gao A; Ahn C; Timmerman R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):196-205.e2. PubMed ID: 28586960
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
9. 5-year results of accelerated partial breast irradiation (APBI) with SBRT (stereotactic body radiation therapy) and exactrac adaptive gating (Novalis
Ciérvide R; Montero Á; Potdevin G; García J; Aranda MG; Álvarez B; Rossi K; López M; Hernando O; Valero J; Sánchez E; Chen X; Alonso R; Letón PF; Rubio C
Clin Transl Oncol; 2021 Nov; 23(11):2358-2367. PubMed ID: 34043153
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction.
Dragun AE; Quillo AR; Riley EC; Roberts TL; Hunter AM; Rai SN; Callender GG; Jain D; McMasters KM; Spanos WJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e123-8. PubMed ID: 23195779
[TBL] [Abstract][Full Text] [Related]
11. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS).
Kraus-Tiefenbacher U; Sfintizky A; Welzel G; Simeonova A; Sperk E; Siebenlist K; Mai S; Wenz F
Radiat Oncol; 2012 Dec; 7():217. PubMed ID: 23249653
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
[TBL] [Abstract][Full Text] [Related]
13. Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer.
Saksornchai K; Rojpornpradit P; Shotelersak K; Lertbutsayanukul C; Chakkabat C; Raiyawa T
J Med Assoc Thai; 2012 Feb; 95(2):229-40. PubMed ID: 22435254
[TBL] [Abstract][Full Text] [Related]
14. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
16. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.
Lemanski C; Azria D; Gourgon-Bourgade S; Gutowski M; Rouanet P; Saint-Aubert B; Ailleres N; Fenoglietto P; Dubois JB
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):698-703. PubMed ID: 19467579
[TBL] [Abstract][Full Text] [Related]
18. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis.
Sanz J; Rodríguez N; Foro P; Dengra J; Reig A; Pérez P; Membrive I; Ortiz A; Codinach M; Algara M
Clin Transl Oncol; 2017 Apr; 19(4):464-469. PubMed ID: 27655367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]